Identifying Market Opportunities Daily

Goldman Sachs just said it plans to spend “tens of millions” on investment on cryptocurrency companies. Goldman Sachs’ head of digital assets, Mathew McDermott, says this could be the right time to snatch up or invest in crypto companies at a discount, said Business...

COVID-19 isn’t through with us just yet. Apparently, cases are ticking higher again in the U.S., raising fears of another wave of infections this winter. According to MarketWatch.com, cases are rising again in 40 states, led by Oklahoma, where cases are up 89% in just...

Keep an eye on Chinese stocks, such as JD.com (JD). The stock is on the move after China relaxed virus testing rules in some cities, signaling that even more easing may be on the way. At the moment, according to CNBC, “Although daily cases hover near all-time highs,...

Beam Therapeutics (BEAM) is on the move in the pre-market—and could see higher highs. All after the company announced the US FDA lifted its clinical hold on its Investigation New Drug Application for BEAM 201. That new drug is being developed to treat relapsed /...

Other traders may be scared of Tesla (TSLA) at the moment, but it looks like an attractive bet on excessive fear. Technically, it’s wildly oversold at prices now seen since early 2021. It’s also over-extended on RSI, MACD, and on Money Flow. From a current price of...

In times of chaos, some of the best stocks to invest in are dividend stocks. In fact, according to The Wall Street Journal, “Dividend stocks have become the new darling on Wall Street, and investors looking for income are pouring billions of dollars into them. These...

On Nov. 25, we spoke about Axsome Therapeutics (AXSM). We noted, “Since June, the stock ran from about $25 to a current price of $56, and it could still run – especially with a number of analysts out with bullish notes. Loop Capital, for example, recently initiated a...